PHARMACEUTICALS covers patent-protected prescription medicines, with news relating to drugmakers, their financial performance, licensing, research and merger & acquisition activities. This also reports on health care markets, patent developments, legislation, product approvals and delays around the globe, backed by a massive archive from which developments in all these areas can be tracked.
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)
Cipher Pharmaceuticals announces FDA approval of CIP-ISOTRETINOIN
Cipher Pharmaceuticals Inc. (TOR:CA:DND) announced today that the US Food and Drug Administration (FDA) has approved Absorica?, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant ...Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)
No comments:
Post a Comment